In fiscal year 2025, JEIL PHARMACEUTICAL (271980) reported revenue of 567.2 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|
| 2025 | 567.2 billion KRW | 20.7 billion KRW | 32.0 billion KRW | [source] |
| 2024 | 704.5 billion KRW | -18.9 billion KRW | -30.1 billion KRW | [source] |
| 2023 | 726.4 billion KRW | 8.7 billion KRW | 5.2 billion KRW | [source] |
| 2022 | 722.2 billion KRW | -13.5 billion KRW | -15.0 billion KRW | [source] |
| 2021 | 700.7 billion KRW | -10.5 billion KRW | -15.0 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|
| 2025 | 450.8 billion KRW | 269.1 billion KRW | 181.7 billion KRW | [source] |
| 2024 | 471.6 billion KRW | 305.8 billion KRW | 165.9 billion KRW | [source] |
| 2023 | 452.5 billion KRW | 273.2 billion KRW | 179.2 billion KRW | [source] |
| 2022 | 428.6 billion KRW | 248.8 billion KRW | 179.8 billion KRW | [source] |
| 2021 | 409.6 billion KRW | 231.7 billion KRW | 177.8 billion KRW | [source] |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|
| 2025 | -5.7 billion KRW | — | — | [source] |
| 2024 | 3.2 billion KRW | -7.3 billion KRW | 23.1 billion KRW | [source] |
| 2023 | -5.0 billion KRW | -11.9 billion KRW | 18.8 billion KRW | [source] |
| 2022 | -15.1 billion KRW | -12.9 billion KRW | 33.6 billion KRW | [source] |
| 2021 | 19.1 billion KRW | -8.0 billion KRW | 11.1 billion KRW | [source] |
Cash flow figures for the relevant year were not collected.
